The decision of the US government to impose a rate of 100% on imported patented medicines from 1 October could weigh on Sun Pharmaceutical Industries, the only major Indian drugstore with considerable exposure to innovative therapies in the US, HSBC said in a report of 26 September. The rate, which excludes companies that build factories […]
